Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence

被引：0
|
作者：
Gomes Gouvea, Maria da Penha [1 ]
Moulaz, Isac Ribeiro [2 ]
Gouveia, Thayna Martins [2 ]
Monlevade Lanca, Karen Evelin [2 ]
de Paula Lacerda, Barbara Sthefany [2 ]
Thompson, Beatriz Paoli [2 ]
Polese, Jessica [3 ]
de Lima, Marina Deorce [2 ]
Ribeiro-Rodrigues, Rodrigo [4 ,5 ]
Mill, Jose Geraldo [6 ]
Valim, Valeria [7 ]
机构：
[1] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio Moraes, Vitoria, ES, Brazil
[2] Univ Fed Espirito Santo, Ctr Ciencias Saude, Vitoria, ES, Brazil
[3] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Pneumol, Vitoria, ES, Brazil
[4] Dept Saude Estado Espirito Santo, Lab Saude Publ Estado Espirito Santo, Vitoria, ES, Brazil
[5] Univ Fed Espirito Santo, Ctr Ciencias Saude, Ctr Doencas Infecciosas, Vitoria, ES, Brazil
[6] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Ciencias Fisiol, Vitoria, ES, Brazil
[7] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio Moraes, Div Reumatol, Vitoria, ES, Brazil
来源：
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL | 2022年 / 55卷
关键词：
COVID-19; SARS-CoV-2; Recurrence; Humoral Reactivity;
D O I：
10.1590/0037-8682-0106-2022
中图分类号：
R38 [医学寄生虫学]; Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ; 100103 ;
摘要：
Background: This study aimed to evaluate IgG and IgM levels in COVID-19 recurrence. Methods: The serum antibody levels and clinical data from 73 healthcare workers with SARS-CoV-2 divided into seroconverted (n=51) and non-seroconverted (n=22) groups were assessed. The presence of specific anti-nucleocapsid (anti-N) IgM and IgG for SARS-CoV-2 was evaluated. IgG antibodies to the SARS-CoV-2 spike receptor-binding domain were used to confirm non-seroconversion in all negative anti-N. Results: Four recurrent cases displayed mild symptoms and were non-seroconverted until the recurrence of symptoms. Conclusions: Undetectable anti-nucleocapsid IgM and IgG levels may be correlated with symptomatic COVID-19 recurrence.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19
    Barrios, Marilou H.
    Nicholson, Suellen
    Bull, Rowena A.
    Martinello, Marianne
    Rawlinson, William
    Mina, Michael
    Post, Jeffrey J.
    Hudson, Bernard
    Gilroy, Nicole
    Lloyd, Andrew R.
    Konecny, Pamela
    Mordant, Francesca
    Catton, Mike
    Subbarao, Kanta
    Caly, Leon
    Druce, Julian
    Netter, Hans J.
    MICROORGANISMS, 2023, 11 (08)
  • [2] Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
    Chen, Yuezhou
    Zuiani, Adam
    Fischinger, Stephanie
    Mullur, Jyotsna
    Atyeo, Caroline
    Travers, Meghan
    Lelis, Felipe J. N.
    Pullen, Krista M.
    Martin, Hannah
    Tong, Pei
    Gautam, Avneesh
    Habibi, Shaghayegh
    Bensko, Jillian
    Gakpo, Deborah
    Feldman, Jared
    Hauser, Blake M.
    Caradonna, Timothy M.
    Cai, Yongfei
    Burke, John S.
    Lin, Junrui
    Lederer, James A.
    Lam, Evan Christopher
    Lavine, Christy L.
    Seaman, Michael S.
    Chen, Bing
    Schmidt, Aaron G.
    Balazs, Alejandro Benjamin
    Lauffenburger, Douglas A.
    Alter, Galit
    Wesemann, Duane R.
    CELL, 2020, 183 (06) : 1496 - +
  • [3] Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient
    Yin, Shengxia
    Tong, Xin
    Huang, Aijun
    Shen, Han
    Li, Yang
    Liu, Yong
    Wu, Chao
    Huang, Rui
    Chen, Yuxin
    JOURNAL OF INFECTION, 2020, 81 (03) : E31 - E32
  • [4] Anti-SARS-CoV-2 Nucleocapsid Antibody Positivity Three Years after COVID-19
    Kang, Chang Kyung
    Kim, Youngju
    Jo, Hyeon Jae
    Lee, Chan Mi
    Kim, Nam Joong
    Lee, Chang-Han
    Choe, Pyoeng Gyun
    Park, Wan Beom
    Oh, Myoung-don
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2024, 77 (05) : 285 - 288
  • [5] Evaluation of Anti-SARS-CoV-2 IgG Antibody in Healthcare Professionals Infected with COVID-19
    Moradveisi, Borhan
    Behzadi, Shirin
    Zakaryaei, Farima
    Jalili, Ali
    Rahmani, Khaled
    Karimi, Avat
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2021, 14 (11)
  • [6] Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19
    Terpos, Evangelos
    Mentis, Andreas
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1695 - 1695
  • [7] Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19
    Kritikos, Antonios
    Gabellon, Sophie
    Pagani, Jean-Luc
    Monti, Matteo
    Bochud, Pierre-Yves
    Manuel, Oriol
    Coste, Alix
    Greub, Gilbert
    Perreau, Matthieu
    Pantaleo, Giuseppe
    Croxatto, Antony
    Lamoth, Frederic
    VIRUSES-BASEL, 2022, 14 (05):
  • [8] Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region
    Markewitz, Robert
    Torge, Antje
    Wandinger, Klaus-Peter
    Pauli, Daniela
    Franke, Andre
    Bujanda, Luis
    Maria Marimon, Jose
    Banales, Jesus M.
    Gutierrez-Stampa, Maria A.
    Nafria, Beatriz
    Junker, Ralf
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region
    Robert Markewitz
    Antje Torge
    Klaus-Peter Wandinger
    Daniela Pauli
    Andre Franke
    Luis Bujanda
    José Maria Marimón
    Jesus M. Banales
    María A. Gutierrez-Stampa
    Beatriz Nafría
    Ralf Junker
    Scientific Reports, 11
  • [10] Evaluating the Value of Anti-SARS-CoV-2 Antibody-Based Tests for COVID-19 Diagnosis
    Yu, Xiao-Lu
    Xie, Jia-Wen
    Wang, Mao
    Lin, Mei-Qi
    Zheng, Ya-Wen
    Lin, Li-Rong
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
12345